Eli Lilly and the Controversy Over US Drug Prices
By Stephanie Vine
August 18, 2025
Eli Lilly says it will increase prices in Europe to “make them lower in the US.”
2 min read
False
By Stephanie Vine
August 18, 2025
Eli Lilly says it will increase prices in Europe to “make them lower in the US.”
2 min read
August 18, 2025
We roundup key announcements from the industry’s big players so far in August.
2 min read
August 18, 2025
Stable isotope ratio mass spectrometry used to assess drug authenticity and consistency.
3 min read
By Jude Lakbub
August 18, 2025
Understanding cell culture media components is crucial – and LC-MS fingerprinting can help.
6 min read
By Corey Ohnmacht, Suzanne Jansen
August 15, 2025
Looking at the importance of stability programs in early clinical drug product development.
4 min read
August 15, 2025
What should the industry do to tackle nitrosamines? It comes down to excipient selection, process control, and predictive tools.
7 min read
August 15, 2025
A consortium of organizations is looking to set new precedents in compound discovery, validation, and clinical success for patients with delayed cerebral ischemia.
4 min read
August 14, 2025
A tale of two cancer drugs: Study suggests that repurposing letrozole and irinotecan can restore memory and reverse pathology in Alzheimer’s model.
3 min read
By Stephanie Vine
August 14, 2025
Targeting disease at the genetic level isn’t science fiction – it’s oligonucleotides. Hilary Brooks reveals how smarter discovery strategies are reshaping what’s possible in drug development.
10 min read
August 13, 2025
From standardizing CAR-T manufacturing to blockchain-backed data sharing, this roundtable tackles what it takes to scale life-saving advanced therapies.
1 min read
False
False
False